Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $7.15B | $45.51 | 3.76% | $49.69M | 284.44x | 1.60 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.13B | $8.24 | 1.48% | $31.73M | 206.00x | 0.46 | Canada | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $7.58B | $71.88 | -1.84% | $136.81M | 53.24x | 0.24 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $4.89B | $169.88 | -0.40% | $102.07M | 54.45x | 0.12 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $610.34M | $7.85 | 0.90% | $10.34M | 71.36x | 0.48 | United States | ||
| SPRY | ARS PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.37B | $13.97 | 0.36% | $8.37M | 174.63x | 0.37 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $913.66M | $9.76 | 1.99% | $19.63M | 69.71x | 0.43 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $39.20B | $645.14 | 2.48% | $114.32M | 42.64x | 0.13 | Belgium | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.95B | $24.29 | 0.04% | $254.32M | 17.60x | 0.17 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.69B | $29.47 | 0.10% | $233.41M | 11.51x | 0.52 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.90B | $38.02 | -3.40% | $23.28M | 181.05x | 0.48 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $10.96B | $39.15 | 1.56% | $737.90M | 21.75x | 0.31 | United States | ||
| SRPT | SAREPTA THERAPEUTICS INC | NASDAQ | Biotechnology | $6.05B | $62.40 | 2.55% | $314.67M | 25.26x | 1.59 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $7.56B | $61.42 | 0.99% | $656.54M | 17.55x | 4.67 | United States | ||
| RIGL | RIGEL PHARMACEUTICALS INC | NASDAQ | Biotechnology | $349.40M | $19.56 | -0.05% | $28.51M | 19.76x | 48.87 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $18.92B | $32.82 | 0.34% | $1.08B | 17.09x | 0.76 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $296.70B | $66.45 | 1.98% | $20.43B | 20.99x | 2.25 | Denmark | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.01B | $6.88 | -0.58% | $66.07M | 23.72x | 0.37 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $5.66B | $23.80 | -1.29% | $147.69M | 28.00x | 0.40 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $12.13B | $62.66 | 3.69% | $406.83M | 216.07x | 0.57 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.53B | $5.04 | 2.65% | $77.54M | 50.40x | -6.00 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.38B | $30.50 | -2.80% | $54.16M | 95.31x | 0.11 | United States | ||
| GNFT | GENFIT SA | NASDAQ | Biotechnology | $204.73M | $4.10 | 1.11% | $9.48M | 120.44x | 1.19 | France | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $7.10B | $116.96 | 0.47% | $1.37B | 12.91x | 1.93 | Ireland | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $12.15B | $63.69 | 0.65% | $650.86M | 28.31x | 0.24 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $7.96B | $50.35 | -0.30% | $312.12M | 50.35x | 0.29 | United States | ||
| ACAD | ACADIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.44B | $14.60 | 1.18% | $273.96M | 10.66x | 0.62 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $14.00B | $21.15 | 1.73% | $1.61B | 12.39x | 0.25 | Denmark | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $13.67B | $303.09 | 0.77% | $1.68B | 11.19x | 0.14 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $64.65B | $598.76 | 5.25% | $5.53B | 14.33x | 0.28 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.